First treatment for Hunter syndrome.
D002675:Child, Preschool; D017277:Drug Approval; D020536:Enzyme Activators / Q000627:therapeutic use*; D006801:Humans; D007066:Iduronate Sulfatase / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D016532:Mucopolysaccharidosis II / Q000188:drug therapy*; D009965:Orphan Drug Production; D035583:Rare Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D020536:Enzyme Activators; D007066:Iduronate Sulfatase; C517982:idursulfase